One potential explanation regarding the difference in Fbxo22 negativity between ILC and IDC, especially ILC in postmenopausal women, might be the differential tumor microenvironment in terms of the estrogen signal transduction pathway between the two histological types. This evidence concerns the gene FBXO22 and neoplasm.